Advanced antisense therapies for postexposure protection against lethal filovirus infections
- PMID: 20729866
- DOI: 10.1038/nm.2202
Advanced antisense therapies for postexposure protection against lethal filovirus infections
Abstract
Currently, no vaccines or therapeutics are licensed to counter Ebola or Marburg viruses, highly pathogenic filoviruses that are causative agents of viral hemorrhagic fever. Here we show that administration of positively charged phosphorodiamidate morpholino oligomers (PMOplus), delivered by various dosing strategies initiated 30-60 min after infection, protects>60% of rhesus monkeys against lethal Zaire Ebola virus (ZEBOV) and 100% of cynomolgus monkeys against Lake Victoria Marburg virus (MARV) infection. PMOplus may be useful for treating these and other highly pathogenic viruses in humans.
Comment in
-
Anti-infectives: Post-exposure antisense protection against lethal filoviruses?Nat Rev Drug Discov. 2010 Oct;9(10):764-5. doi: 10.1038/nrd3279. Nat Rev Drug Discov. 2010. PMID: 20885406 No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources